| Current Price | $73.88 | Mkt Cap | $7.6B |
|---|---|---|---|
| Open | $75.44 | P/E Ratio | 49.29 |
| Prev. Close | $73.88 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $73.87 - $75.86 | Volume | 405,731 |
| 52-Wk Range | $52.60 - $81.78 | Avg. Daily Vol. | 478,001 |
| Current Price | $73.88 | Mkt Cap | $7.6B |
|---|---|---|---|
| Open | $75.44 | P/E Ratio | 49.29 |
| Prev. Close | $73.88 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $73.87 - $75.86 | Volume | 405,731 |
| 52-Wk Range | $52.60 - $81.78 | Avg. Daily Vol. | 478,001 |
The best Bull and Bear pitches based on recency and number of recommendations.
currently profitable with slow steady growth... but are just breaking into the robotics surgery market with their new robotics surgery system for spine surgery - the first of its kind (ISRG is soft tissue, GMED is bone)
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about GMED.
Recs
KPowersUSMC
(< 20)
Submitted: 9/16/2021 4:17:26 PM :
Start Price:
$81.54
NYSE:GMED Score:
+0.54
Bringing a new way into the medical field.
Recs
jjhegi
(43.36)
Submitted: 12/12/2020 9:58:53 PM :
Start Price:
$55.24
NYSE:GMED Score:
+14.55
Growing revenues and profitable each of the last 5 years. Founder and CEO owns large chunk of the company and still closely involved. Already profitable and its new ExelciusGPS system could lead to explosive growth. Strong balance sheet and strong free cashflow makes this a low-risk bet with high reward potential.
Recs
andyy
(22.56)
Submitted: 8/9/2020 8:58:20 AM :
Start Price:
$57.81
NYSE:GMED Score:
+8.20
Just started with Stock Advisor and went with Best Buy's and Top Recommendations.
Find the members with the highest scoring picks in GMED.
pungocatfish (< 20) Score: +400.84
The Score Leader is the player with the highest score across all their picks in GMED.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| pungocatfish | < 20 | 1/3/2013 |
|
3Y | $10.94 | +575.32% | +174.48% | +400.84 | 0 Comment | |
| Squeege1981 | 68.00 | 12/24/2012 |
|
3Y | $10.96 | +574.09% | +181.25% | +392.84 | 0 Comment | |
| PerdidoBeacher | 49.33 | 12/20/2012 |
|
5Y | $11.34 | +551.50% | +177.55% | +373.95 | 0 Comment | |
| Biotechnut | < 20 | 12/3/2012 |
|
5Y | $12.05 | +513.11% | +182.73% | +330.38 | 0 Comment | |
| jayimsu | < 20 | 4/30/2013 |
|
5Y | $14.79 | +399.53% | +151.60% | +247.93 | 0 Comment | |
| Santa007 | < 20 | 8/15/2012 |
|
3Y | $14.32 | +415.89% | +184.44% | +231.45 | 2 Comments | |
| NewClueLess | 34.13 | 11/11/2013 |
|
5Y | $18.52 | +298.92% | +126.24% | +172.68 | 0 Comment | |
| jsnms | 22.91 | 12/17/2013 |
|
5Y | $19.10 | +286.81% | +123.42% | +163.39 | 0 Comment | |
| sandvig | 96.23 |
|
|
5Y | $21.61 | +241.88% | +84.41% | +157.47 | 0 Comment | |
| TravelinLight | 24.77 | 12/31/2013 |
|
5Y | $20.01 | +269.22% | +117.45% | +151.76 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
